{{Rsnum
|rsid=11600901
|Gene=SCN2B
|Chromosome=11
|position=118161271
|Orientation=plus
|GMAF=0.05739
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 17.9 | 81.2
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 1.8 | 98.2
| YRI | 0.0 | 2.0 | 98.0
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 2.8 | 97.2
| GIH | 1.0 | 19.8 | 79.2
| LWK | 0.0 | 4.5 | 95.5
| MEX | 3.4 | 8.6 | 87.9
| MKK | 0.0 | 7.7 | 92.3
| TSI | 2.0 | 20.6 | 77.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23551011
  |Trait=Preeclampsia
  |Title=Genome-Wide Association Study of Pre-Eclampsia Detects Novel Maternal Single Nucleotide Polymorphisms and Copy-Number Variants in Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study Cohort.
  |RiskAllele=
  |Pval=9E-6
  |OR=9.83
  |ORtxt=[3.58-27.00]
  }}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}